Back to Archived Journals » Core Evidence » Volume 5 » default

Core Evidence ceased publishing in February 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Archive: Volume 5, 2010

Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

Douglas R Jeffery, Emily Poole Pharr

Core Evidence 2010, 5:107-112

Published Date: 8 December 2010

Pitavastatin: evidence for its place in treatment of hypercholesterolemia

Peter Alagona, Jr

Core Evidence 2010, 5:91-105

Published Date: 22 October 2010

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al

Core Evidence 2010, 5:61-76

Published Date: 24 September 2010

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Renee M Sullivan, Brian Olshansky

Core Evidence 2010, 5:49-59

Published Date: 15 September 2010

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Sonia Okuyama, Rene Gonzalez, Karl D Lewis

Core Evidence 2010, 5:39-48

Published Date: 1 September 2010

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Kristen Kulasa, Steven Edelman

Core Evidence 2010, 5:23-37

Published Date: 13 August 2010

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Eliana Krulig, Kenneth B Gordon

Core Evidence 2010, 5:11-22

Published Date: 5 July 2010

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Markos Poulopoulos, Cheryl Waters

Core Evidence 2010, 5:1-10

Published Date: 22 December 2009